Neuropeptide y damages the integrity of mitochondrial structure and disrupts energy metabolism in cultured neonatal rat cardiomyocytes

Peptides

Volumn 71, Issue , 2015, Pages 162-169

  Luo, Guochang ^a,b   Xu, Xuehua ^c   Guo, Wei ^a   Luo, Chengliang ^c   Wang, Hao ^a   Meng, Xiangzhi ^a   Zhu, Shaohua ^c   Wei, Yan ^b  

^a WUHAN UNIVERSITY   (China)

^b Nanyang Medical College   (China)

^c SOOCHOW UNIVERSITY   (China)

Author keywords

Energy metabolism; Mitochondrial membrane potential; Mitochondrial structure; Neuropeptide Y; Proliferator activated receptor coactivator 1alpha

Indexed keywords

ADENOSINE TRIPHOSPHATE; MESSENGER RNA; NEUROPEPTIDE Y; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PROTEIN; PPARGC1A PROTEIN, RAT; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; BIOLUMINESCENCE; CELL ACTIVITY; CELL COUNTING; CELL COUNTING KIT 8; CELL FUNCTION; CELL ISOLATION; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; ENERGY METABOLISM; HEART CELL CULTURE; HEART MUSCLE CELL; IN VITRO STUDY; JC 1 STAINING; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR UPREGULATION; STAINING; TRANSMISSION ELECTRON MICROSCOPY; ANIMAL; BIOSYNTHESIS; CARDIAC MUSCLE CELL; CELL CULTURE; DRUG EFFECTS; GENE EXPRESSION REGULATION; HEART MITOCHONDRION; METABOLISM; PATHOLOGY;

RATTUS;

ANIMALS; CELLS, CULTURED; ENERGY METABOLISM; GENE EXPRESSION REGULATION; MITOCHONDRIA, HEART; MYOCYTES, CARDIAC; NEUROPEPTIDE Y; RATS; TRANSCRIPTION FACTORS;

EID: 84938384709     PISSN: 01969781     EISSN: 18735169     Source Type: Journal    
DOI: 10.1016/j.peptides.2015.07.001     Document Type: Article

References (40)

1. K. Abe, L. Kuo, and Z. Zukowska Neuropeptide Y is a mediator of chronic vascular and metabolic maladaptations to stress and hypernutrition Exp. Biol. Med. (Maywood) 235 2010 1179 1184
2. S. Ananda, Y. Wang, S. Zhu, R. Wang, X. Zhou, L. Zhuo, and et al. Role of neuropeptide Y and peroxisome proliferator-activated receptor gamma coactivator-1alpha in stress cardiomyopathy J. Huazhong Univ. Sci. Technol. Med. Sci. 32 2012 823 828
3. P.M. Barger, A.C. Browning, A.N. Garner, and D.P. Kelly p38 mitogen-activated protein kinase activates peroxisome proliferator-activated receptor alpha: a potential role in the cardiac metabolic stress response J. Biol. Chem. 276 2001 44495 44501
4. Bi S. Role of NPY in Brown Adipocytes and Obesity. (2013), 169-86.
5. M. Carlquist, H. Jornvall, K. Tatemoto, and V. Mutt A porcine brain polypeptide is identical to the vasoactive intestinal polypeptide Gastroenterology 83 1982 245 249
6. Chambers AP, Woods SC. The role of neuropeptide Y in energy homeostasis. Handbook of experimental pharmacology. (2012), 23-45.
7. M. Chen, X. Li, Q. Dong, Y. Li, and W. Liang Neuropeptide Y induces cardiomyocyte hypertrophy via calcineurin signaling in rats Regul. Pept. 125 2005 9 15
8. Y. Chen, Y. Wang, J. Chen, X. Chen, W. Cao, S. Chen, and et al. Roles of transcriptional corepressor RIP140 and coactivator PGC-1α in energy state of chronically infarcted rat hearts and mitochondrial function of cardiomyocytes Mol. Cell. Endocrinol. 362 2012 11 18
9. F. Cuculi, N. Herring, A.R. De Caterina, A.P. Banning, B.D. Prendergast, J.C. Forfar, and et al. Relationship of plasma neuropeptide Y with angiographic, electrocardiographic and coronary physiology indices of reperfusion during ST elevation myocardial infarction Heart 99 2013 1198 1203
10. Duncan JG, Finck BN. PPAR/PGC-1 Regulation of Metabolism in Cardiac Disease. (2012), 83-111.
11. M.C. Dvorakova, P. Kruzliak, and S.W. Rabkin Role of neuropeptides in cardiomyopathies Peptides 61C 2014 1 6
12. F. Forini, G. Nicolini, and G. Iervasi Mitochondria as key targets of cardioprotection in cardiac ischemic disease: role of thyroid hormone triiodothyronine Int. J. Mol. Sci. 16 2015 6312 6336
13. C. Handschin The biology of PGC-1alpha and its therapeutic potential Trends Pharmacol. Sci. 30 2009 322 329
14. N. Herring Autonomic control of the heart: going beyond the classical neurotransmitters Exp. Physiol. 100 2015 354 358
15. C.M. Hostetler, L.N. Hitchcock, A.M. Anacker, L.J. Young, and A.E. Ryabinin Comparative distribution of central neuropeptide Y (NPY) in the prairie (Microtus ochrogaster) and meadow (M. pennsylvanicus) vole Peptides 40 2013 22 29
16. S. Jayaraman Flow cytometric determination of mitochondrial membrane potential changes during apoptosis of T lymphocytic and pancreatic beta lines: comparison of tetramethylrhodamineethylester (TMRE), chloromethyl-X-rosamine (H2-CMX-Ros) and MitoTracker Red 580 (MTR580) J. Immunol. Methods 306 2005 68 79
17. K. Kaczynska, and M. Szereda-Przestaszewska NPY Y(1) receptors are involved in cardio-respiratory responses to intravenous injection of neuropeptide Y in anaesthetized rats Pharmacol. Res. 62 2010 444 449
18. G. Klug, R.H. Zwick, A. Mayr, M.F. Schocke, P. Steinboeck, W. Jaschke, and et al. Correlation of cardiovascular risk scores with myocardial high-energy phosphate metabolism Int. J. Cardiol. 150 2011 208 210
19. S. Koene, and J. Smeitink Metabolic manipulators: a well founded strategy to combat mitochondrial dysfunction J. Inherit. Metab. Dis. 34 2011 315 325
20. D. Larhammar, and E. Salaneck Molecular evolution of NPY receptor subtypes Neuropeptides 38 2004 141 151
21. Y. Lin, Y. Zhao, R. Li, J. Gong, Y. Zheng, and Y. Wang PGC-1α is associated with C2C12 Myoblast differentiation Cent. Eur. J. Biol. 9 2014 1030 1036
22. C.L. Luo, X.P. Chen, L.L. Li, Q.Q. Li, B.X. Li, A.M. Xue, and et al. Poloxamer 188 attenuates in vitro traumatic brain injury-induced mitochondrial and lysosomal membrane permeabilization damage in cultured primary neurons J. Neurotrauma 30 2013 597 607
23. C.L. Luo, B.X. Li, Q.Q. Li, X.P. Chen, Y.X. Sun, H.J. Bao, and et al. Autophagy is involved in traumatic brain injury-induced cell death and contributes to functional outcome deficits in mice Neuroscience 184 2011 54 63
24. I. Manoli, S. Alesci, M.R. Blackman, Y.A. Su, O.M. Rennert, and G.P. Chrousos Mitochondria as key components of the stress response Trends Endocrinol. Metab. 18 2007 190 198
25. R. Matyal, L. Chu, F. Mahmood, M.P. Robich, A. Wang, P.E. Hess, and et al. Neuropeptide Y improves myocardial perfusion and function in a swine model of hypercholesterolemia and chronic myocardial ischemia J. Mol. Cell. Cardiol. 53 2012 891 898
26. J. Mori, L. Zhang, G.Y. Oudit, and G.D. Lopaschuk Impact of the renin-angiotensin system on cardiac energy metabolism in heart failure J. Mol. Cell. Cardiol. 63 2013 98 106
27. E. Potter Presynaptic inhibition of cardiac vagal postganglionic nerves by neuropeptide Y Neurosci. Lett. 83 1987 101 106
28. C. Riehle, A.R. Wende, V.G. Zaha, K.M. Pires, B. Wayment, C. Olsen, and et al. PGC-1 deficiency accelerates the transition to heart failure in pressure overload hypertrophy Circ. Res. 109 2011 783 793
29. G.C. Rowe, S. Raghuram, C. Jang, J.A. Nagy, I.S. Patten, A. Goyal, and et al. PGC-1alpha induces SPP1 to activate macrophages and orchestrate functional angiogenesis in skeletal muscle Circ. Res. 115 2014 504 517
30. J. Shoag, and Z. Arany Regulation of hypoxia-inducible genes by PGC-1 alpha Arterioscler. Thromb. Vasc. Biol. 30 2010 662 666
31. S. Szardien, H. Mollmann, S. Voss, C. Troidl, A. Rolf, C. Liebetrau, and et al. Elevated serum levels of neuropeptide Y in stress cardiomyopathy Int. J. Cardiol. 147 2011 155 157
32. K. Tatemoto, M. Carlquist, and V. Mutt Neuropeptide Y-a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide Nature 296 1982 659 660
33. A.T. Turer Using metabolomics to assess myocardial metabolism and energetics in heart failure J. Mol. Cardiol. 55 2013 12 18
34. Y. Wan, R. Xue, Y. Wang, Q. Zhang, S. Huang, W. Wu, and et al. The effect of neuropeptide Y on brown-like adipocyte's differentiation and activation Peptides 63C 2014 126 133
35. S. Wang, J. Chen, G. Yue, M. Bai, M. Kou, and Z. Jin Neuropeptide Y and leptin receptor expression in the hypothalamus of rats with chronic immobilization stress Neural. Regen. Res. 8 2013 1721 1726
36. M.R. Warner, and M.N. Levy Inhibition of cardiac vagal effects by neurally released and exogenous neuropeptide Y Circ. Res. 65 1989 1536 1546
37. T. Wenz Regulation of mitochondrial biogenesis and PGC-1alpha under cellular stress Mitochondrion 13 2013 134 142
38. K. Yalta, N. Sivri, and T. Yalta Neuropeptide Y-induced coronary microvascular dysfunction: a significant contributor to the adverse outcomes in stress cardiomyopathy? Int. J. Cardiol. 147 2011 284
39. X.M. Zhang, F. Shen, Z.Y. Xv, Z.Y. Yan, and S. Han Expression changes of thrombospondin-1 and neuropeptide Y in myocardium of STZ-induced rats Int. J. Cardiol. 105 2005 192 197
40. H.C. Zhao, Z.B. Liu, Q.L. Feng, X.L. Cui, C.M. Zhang, and B.W. Wu [Effects of neuropeptide Y on ion channels in ventricular myocytes] Sheng Li Xue Bao 58 2006 225 231